New Key Statistics Module, Z-Score and F-Score
GREY:ARBQY Key Ratios
Market Cap $ M | -- |
Enterprise Value $ M | 6,589.53 |
P/E(ttm) | 26.14 |
PE Ratio without NRI | 25.62 |
Forward PE Ratio | -- |
Price/Book | 2.57 |
Price/Sales | 2.63 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 95.65 |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -- |
Beneish M-Score | -2.47 |
10-y EBITDA Growth Rate % | 16.00 |
5-y EBITDA Growth Rate % | 3.40 |
y-y EBITDA Growth Rate % | 51.80 |
EV-to-EBIT | 17.35 |
EV-to-EBITDA | 12.70 |
PEG | 7.54 |
Shares Outstanding M | 585.92 |
Net Margin (%) | 10.04 |
Operating Margin % | 13.30 |
Pre-tax Margin (%) | 14.06 |
Quick Ratio | 1.10 |
Current Ratio | 1.81 |
ROA % (ttm) | 6.87 |
ROE % (ttm) | 10.32 |
ROIC % (ttm) | 8.97 |
Dividend Yield % | -- |
Altman Z-Score | 3.99 |
ARBQY Number of Guru Trades
ARBQY Volume of Guru Trades
Gurus Latest Trades with GREY:ARBQY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:ARBQY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aurobindo Pharma Ltd Insider Transactions
No Available Data
News about GREY:ARBQY
Total 0- 1